Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Dewatripont

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|August 23, 2018
Free Drug Samples and the Opioid CrisisMathias Dewatripont, Michel Goldman
Medecine Sciences : M/S|November 30, 2022
[Therapeutic innovation for the common good]Michel Goldman, Mathias Dewatripont, Alain Fischer
Nature Medicine|November 27, 2019
Benefit Corporation: a path to affordable gene therapies?Alain Fischer, Mathias Dewatripont, Michel Goldman
Medecine Sciences : M/S|May 2, 2020
[What is the fair price of innovative therapy?]Alain Fischer, Mathias Dewatripont, Michel Goldman
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 29, 2023
Prescription opioids and economic hardship in FranceIlaria Natali, Mathias Dewatripont, Victor Ginsburgh, et al.
Nature Reviews. Drug Discovery|August 22, 2023
A novel approach to boost drug development in paediatric oncologySam Daems, Hilde Stevens, Mathias Dewatripont, et al.
Nature Medicine|May 15, 2020
Preparing for a responsible lockdown exit strategyMarius Gilbert, Mathias Dewatripont, Eric Muraille, et al.
BMC Public Health|November 18, 2023
Assessing the impact of COVID-19 passes and mandates on disease transmission, vaccination intention, and uptake: a scoping reviewYessika Adelwin Natalia, Margaux Delporte, Dries De Witte, et al.
International Journal of Environmental Research and Public Health|December 10, 2021
Confirmed COVID-19 Cases per Economic Activity during Autumn Wave in BelgiumJohan Verbeeck, Godelieve Vandersmissen, Jannes Peeters, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|August 23, 2018
Free Drug Samples and the Opioid CrisisMathias Dewatripont, Michel Goldman
Medecine Sciences : M/S|November 30, 2022
[Therapeutic innovation for the common good]Michel Goldman, Mathias Dewatripont, Alain Fischer
Nature Medicine|November 27, 2019
Benefit Corporation: a path to affordable gene therapies?Alain Fischer, Mathias Dewatripont, Michel Goldman
Medecine Sciences : M/S|May 2, 2020
[What is the fair price of innovative therapy?]Alain Fischer, Mathias Dewatripont, Michel Goldman
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 29, 2023
Prescription opioids and economic hardship in FranceIlaria Natali, Mathias Dewatripont, Victor Ginsburgh, et al.
Nature Reviews. Drug Discovery|August 22, 2023
A novel approach to boost drug development in paediatric oncologySam Daems, Hilde Stevens, Mathias Dewatripont, et al.
Nature Medicine|May 15, 2020
Preparing for a responsible lockdown exit strategyMarius Gilbert, Mathias Dewatripont, Eric Muraille, et al.
BMC Public Health|November 18, 2023
Assessing the impact of COVID-19 passes and mandates on disease transmission, vaccination intention, and uptake: a scoping reviewYessika Adelwin Natalia, Margaux Delporte, Dries De Witte, et al.
International Journal of Environmental Research and Public Health|December 10, 2021
Confirmed COVID-19 Cases per Economic Activity during Autumn Wave in BelgiumJohan Verbeeck, Godelieve Vandersmissen, Jannes Peeters, et al.
Pageof 1